UCB Japan Co., Ltd. Obtains FDA Approval Of Treatment Drug For Epilepsy Patients
8/14/2006 1:26:42 PM
More...
|
UCB Japan Co., Ltd. Announces Sales Channel Change Of Zyrtec Tablet In Japan
10/19/2005 5:13:08 PM
More...
|
UCB Japan Co., Ltd. Adopts Dendrite International, Inc.'s (DRTE) j-forceNET For Sales Force In Japanese Market
10/19/2005 5:13:04 PM
More...
|
Neogen Corporation (NEOG) To Acquire UCB Group's (UCBJF.PK) Dairy Antibiotic Testing Business
10/19/2005 5:09:25 PM
More...
|
GlaxoSmithKline (GSK) , UCB Japan Co., Ltd. To Jointly Promote Immunosuppressant Medication, Imuran Tablets
10/19/2005 5:09:21 PM
More...
|
UCB Japan Co., Ltd. , Daiichi Pharmaceutical (JPN) To Reinforce Their Collaboration For Antiallergic Agent Zyrtec
10/19/2005 5:09:04 PM
More...
|
UCB Japan Co., Ltd. To License H2-Receptor Antagonist STOGAR tab. To Korean Pharmaceutical Boryung Pharmaceuticals Co., Ltd.
10/19/2005 5:08:45 PM
More...
|